Yangzhou Medline Industry Co., Ltd. (hereinafter called "MEDLINE") ,authorized by State Food and Drug Administration, is a state-recognized professional manufacturer of disposable sterile medical appliances. Located in the beautiful and historical city Yangzhou, it is quite near Shanghai and Nanjing .

Since 2007,MEDLINE has started production.It covers 15000 square meters, 8800 square meters of which are workshops, and the GMP standard 100,000 cleanroom are 3600 square meters. There are more than 150 staffs working for MEDLINE.

With the idea of "people-oriented", and company principle of "care for life, quality first,technological innovation, high efficiency", on the basis of international standard, MEDLINE has got high reputation in the international markets,such as Latin America, Europe, USA etc.

Now, MEDLINE has owned research and development center of 15 engineers and 25 patents,most of which are safety products.And one of them is inventive patent for safety needles.MEDLINE's main products include safety syringes,safety needles, safety scalp vein set, safety blood collection needles, safety insulin syringes, auto-destroy syringes, super urine bags, insulin syringes, disposable syringes, three-way stopcocks, spinal needles, surgical brushes etc. Among them,especially safety products have gained acknowledgement and appreciation all over the world.

Within short years, MEDLINE’s all products have passed ISO9001, ISO13485, CE0197, FDA, BV,GMP certificates. Meantime, MEDLINE is also honored as High Integrity Enterprise by JSFDA and the first Chinese company to acquire INMETRO certificate in Brazil .

In 2020, Medline's new workshop has been put into production, covering a total area of 30,000 square meters and a purification workshop of 11,000 square meters. Medical masks, Surgical masks, Medical protective masks, KN95 masks, Safety vaccine syringes and Retractable insulin syringes are being officially put into production. At present, our masks have been successfully certified with EN14683, EN149 FFP2, TGA, and relevant Chinese registration certificates (GB2626, GB19083, YY0469, YY0969).

With the change of the international market, MEDLINE has begun the development in the domestic markets on the basis of export. Meanwhile, MEDLINE will go on implementing strategy of "markets development, products innovation", developing more products with high-tech and values for high-profile customers in the world, and sparing no efforts for the development of MEDLINE and favor of patients.